CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Category III Rabies Exposure Risks

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04644484
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:12.273133+00:00
Published At: 2023-04-21T00:00:00+00:00
Record Updated At: 2023-04-21
Results Posted At: 2023-04-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rabies", "Communicable Disease", "Virus Diseases", "Rhabdoviridae Infections", "Mononegavirales Infections", "RNA Virus Infections"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-04-21"
protocolSection.identificationModule.nctId: "NCT04644484"
protocolSection.identificationModule.officialTitle: "A Phase III Randomized Blinded Study to Evaluate SYN023 Compared to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies in Adults With Category III Rabies Exposure Risks"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-04-21"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.